Cocaine choice in humans during D-amphetamine maintenance

Journal of Clinical Psychopharmacology

Volumn 30, Issue 2, 2010, Pages 152-159

  Rush, Craig R ^a,b   Stoops, William W ^a   Sevak, Rajkamur J ^a   Hays, Lon R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Agonist replacement therapy; Choice; Cocaine; D amphetamine; Drug reinforcement; Humans; Pharmacotherapy; Physiological effects; Subjective effects

Indexed keywords

AMPHETAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOANALYSIS; WITHDRAWAL SYNDROME;

ADULT; BEHAVIOR, ADDICTIVE; CHOICE BEHAVIOR; COCAINE; COCAINE-RELATED DISORDERS; DEXTROAMPHETAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 77952201761     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181d21967     Document Type: Article

References (38)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). National Survey on Drug Use and Health (NSDUH), 2006. Available at: http://www.samhsa.gov/, 2008a. Accessed February 15, 2008.
2. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). Drug Abuse Warning Network (DAWN), 2005. Available at: http://www.samhsa.gov/, 2008b. Accessed February 15, 2008.
3. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). Treatment Episode Data Set (TEDS): 1995-2005. National Admissions to Substance Abuse Treatment Services. 2008c. Available at: http://www.samhsa.gov/. Accessed February 15, 2008.
4. Covi L, Hess JM, Schroeder JR, et al. A dose response study of cognitive behavioral therapy in cocaine abusera. J Subst Abuse Treat. 2002; 23: 191-197. (Pubitemid 35254161)
5. MeKee SA, Carroll KM, Sinha R, et al. Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users. Drug Alcohol Depend. 2007; 91: 97-101. (Pubitemid 47385030)
6. Higgins ST, Budney AJ, Bickel WK, et al. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry. 1993a; 150: 63-69.
7. Higgins ST, Alessi SM, Dantona RL. Voucher-based incentives. A substance abuse treatment innovation. Addict Behav. 2002; 27: 887-910. (Pubitemid 36163351)
8. Higgins ST, Heil SH, Lussier JP. Clinical implications of reinforcement as a determinant of substance use disorders. Annu Rev Psychol. 2004; 55: 431-461. (Pubitemid 40505734)
9. Vocci FJ, Montoya ID. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry. 2009; 22: 263-268.
10. de Lima MS, de Oliveira Soares BG, Reisser AA, et al. Pharmacological treatment of cocaine dependence: a systematic review. Addiction. 2002; 97: 931-949.
11. Vocci FJ, Elkashef A. Pharmacotherapy and other treatments for cocaine abuse and dependence. Curr Opin Psychiatry. 2005; 18: 265-270. (Pubitemid 40586109)
12. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med. 1995; 333: 1196-1203.
13. Ling W, Rawson. RA, Compton MA, Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J Psychoactive Drugs. 1994; 26: 119-128. (Pubitemid 24218150)
14. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008; (1): CD000146. (Pubitemid 351807619)
15. Sofuoglu M, Kosten TR. Pharmacologic management of relapse prevention in addictive disorders. Psychiatr Clin North Am. 2004; 27: 627-648. (Pubitemid 39535120)
16. Chiodo KA, Lack CM, Roberts DC. Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology (Berl). 2008; 200: 465-473.
17. Negus SS. Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with D-amphetamine and flupenthixol. Neuropsychopharmacology. 2003; 28: 919-931.
18. Negus SS, Mello NK. Effects of chronic D-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology. 2003a; 167: 324-332. (Pubitemid 36712980)
19. Negus SS, Mello NK, Effects of chronic D-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend. 2003b; 70: 39-52. (Pubitemid 36385152)
20. Peltier RL, Li DH, Lytle D, et al. Chronic D-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine. J Pharmacol Exp Ther. 1996; 277: 212-218. (Pubitemid 27169063)
21. Skinner HA. The drug abuse screening test. Addict Behav. 1982; 7: 363-371.
22. Selzer ML. The Michigan Alcoholism. Screening Test; the quest for a new diagnostic instrument. Am J Psychiatry. 1971; 127: 1653-1658.
23. Dudish-Poulsen SA, Hatsukami DK. Dissociation between subjective and behavioral responses after cocaine stimuli presentation. Drug Alcohol Depend. 1997; 47: 1-9.
24. Oliveto AH, Bickel WK, Hughes JR, et al. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther. 1992; 261: 885-894.
25. Rush CR, Stoops WW, Hays LR. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend. 2009; 99: 261-271.
26. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand. 1987; 334(suppl): 1-100. (Pubitemid 17115352)
27. Fischman MW, Foltin RW, Nestadt G, et al. Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther. 1990; 253: 760-770. (Pubitemid 20181724)
28. Collins SL, Levin FR, Foltin RW, et al. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend. 2006 ;82: 158-167.
29. Freireich EJ, Gehan EA, Rail DP, et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966; 50: 219-244.
30. Grabowski J, Rhoades H, Schmitz J, et al. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol. 2001; 21: 522-526. (Pubitemid 32937435)
31. Hart CL, Ward AS, Collins ED, et al. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend. 2004; 73: 279-287.
32. Hart CL, Haney M, Vosburg SK, et al. Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol. 2007; 18: 71-75. (Pubitemid 46103285)
33. Stoops WW, Blackburn JW, Hudson DA, et al. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. Drug Alcohol Depend. 2008; 92: 282-285.
34. Walsh SL, Haberny KA, Bigelow GE. Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology (Berl). 2000; 150: 361-373.
35. Winhusen T, Somoza E, Singal BM, et al. Methylphenidate and cocaine: a placebo-controlled drug interaction study. Pharmacol Biochem Behav. 2006; 85: 29-38. (Pubitemid 44772906)
36. Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther. 1996; 278: 1153-1164.
37. Haney M, Hart CL, Foltin RW. Effects of baclofen on cocaine self-administration; opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology. 2006; 31: 1814-1821 (Pubitemid 44106713)
38. Castells X, Casas M, Vidal X, et al. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. Addiction. 2007; 102: 1871-1887.